Clinical trial · Observational
Multimodality Treatment Including Curative Resection of Advanced NSCLC
Multimodality Treatment Including Curative Resection of Advanced Stage Non-small Cell Lung Cancer - an Explorative, Retrospective Pilot Study
NCT04455984CI-TRIAL-00045807unknownClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study retrospectively evaluates clinical parameters and outcome of patients with advanced stage non-small cell lung cancer treated with neoadjuvant therapy followed by curative-intent surgery at the Divison of Thoracic Surgery at the Medical University of Vienna
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Advanced Non-small-cell Lung Cancer | Lung Non-Small Cell Carcinoma | CURATED_BROADER | 0.78 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Date collection | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Neoadjuvant chemoradiotherapy
- description
- Patients with advanced NSCLC treated with neoadjuvant platinum-based chemoradiotherapy followed by curative-intent surgery
- interventionNames
- Other: Date collection
- label
- Neoadjuvant chemotherapy
- description
- Patients with advanced NSCLC treated with neoadjuvant platinum-based chemotherapy followed by curative-intent surgery
- interventionNames
- Other: Date collection
Primary outcomes (1)
- measure
- Overall survival
- timeFrame
- 18 years
- description
- * Overall survival of stage III NSCLC in resectable patients undergoing induction treatment and curative intent surgery * Overall survival of stage III NSCLC in resectable patients undergoing induction treatment and curative intent surgery * Overall survival of stage III NSCLC in resectable patients undergoing induction treatment and curative intent surgery Overall survival of stage III NSCLC in resectable patients undergoing induction treatment and curative intent surgery
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with advanced NSCLC and multimodality treatment including curative-intent resection Exclusion Criteria: * Patients with early stage NSCLC * Patients with advanced NSCLC without multimodality treatment * Patients without curative resection
References
Publications (0)
Data not yet available
No reference posted for this study.